Ryan Vandrey, Ph.D.

Psychiatry and Behavioral Sciences Johns Hopkins University, Baltimore, MD 
"Ryan Vandrey"
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Lee DC, Schlienz NJ, Herrman ES, et al. (2023) Randomized controlled trial of zolpidem as a pharmacotherapy for cannabis use disorder. Journal of Substance Use and Addiction Treatment. 209180
Dowd AN, Zamarripa CA, Sholler DJ, et al. (2023) A cross-sectional survey on cannabis: Characterizing motives, opinions, and subjective experiences associated with the use of various oral cannabis products. Drug and Alcohol Dependence. 245: 109826
Kiluk BD, Kleykamp BA, Comer SD, et al. (2022) Clinical Trial Design Challenges and Opportunities for Emerging Treatments for Opioid Use Disorder: A Review. Jama Psychiatry
Meier E, Rubin N, Dermody SS, et al. (2022) Immediate Switching to Reduced Nicotine Cigarettes in a U.S.-Based Sample: The Impact on Cannabis Use and Related Variables at 20 Weeks. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco
Garcia-Romeu A, Elmore J, Mayhugh RE, et al. (2022) Online survey of medicinal cannabis users: Qualitative analysis of patient-level data. Frontiers in Pharmacology. 13: 965535
Klemperer EM, Luo X, Jensen J, et al. (2022) Smoking abstinence and cessation-related outcomes one month after an immediate versus gradual reduction in nicotine content of cigarettes. Preventive Medicine. 107175
Lapham GT, Matson TE, Carrell DS, et al. (2022) Comparison of Medical Cannabis Use Reported on a Confidential Survey vs Documented in the Electronic Health Record Among Primary Care Patients. Jama Network Open. 5: e2211677
Martin EL, Strickland JC, Schlienz NJ, et al. (2021) Antidepressant and Anxiolytic Effects of Medicinal Cannabis Use in an Observational Trial. Frontiers in Psychiatry. 12: 729800
Strickland JC, Jackson H, Schlienz NJ, et al. (2021) Cross-sectional and longitudinal evaluation of cannabidiol (CBD) product use and health among people with epilepsy. Epilepsy & Behavior : E&B. 122: 108205
Sholler DJ, Moran MB, Dolan SB, et al. (2021) Use patterns, beliefs, experiences, and behavioral economic demand of indica and sativa cannabis: A cross-sectional survey of cannabis users. Experimental and Clinical Psychopharmacology
See more...